Taken together, TGF-β induction of epithelial-mesenchymal transition, promoting tumor invasion and metastasis,[39] along with its further activation of tumor angiogenesis and cancer-associated fibroblasts, enabling immune response evasion,[40] may explain the poor prognosis observed in the high-risk group. The gene discussed is TGFB1; the disease is cancer.